KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 160 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $131,000 | +4266.7% | 29,111 | +6080.7% | 0.01% | – |
| Q1 2022 | $3,000 | -62.5% | 471 | -62.6% | 0.00% | – |
| Q4 2021 | $8,000 | -87.3% | 1,258 | -88.3% | 0.00% | -100.0% |
| Q3 2021 | $63,000 | +2000.0% | 10,774 | +3503.3% | 0.00% | – |
| Q1 2021 | $3,000 | -85.0% | 299 | -78.3% | 0.00% | -100.0% |
| Q3 2020 | $20,000 | -67.2% | 1,379 | -57.1% | 0.00% | -71.4% |
| Q2 2020 | $61,000 | +190.5% | 3,213 | +194.5% | 0.01% | -22.2% |
| Q1 2020 | $21,000 | +950.0% | 1,091 | +305.6% | 0.01% | +800.0% |
| Q2 2019 | $2,000 | +100.0% | 269 | +232.1% | 0.00% | – |
| Q3 2018 | $1,000 | -50.0% | 81 | -22.9% | 0.00% | -100.0% |
| Q2 2018 | $2,000 | -33.3% | 105 | -68.6% | 0.00% | -50.0% |
| Q4 2017 | $3,000 | – | 334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |